When you arrive in Orlando, make your way to the registration desk (Convention Level) to receive your conference badge and essential materials, ensuring you're fully equipped for ACRP 2026.
If you have questions or need assistance throughout the conference, the registration desk is where you’ll find the answers you seek.
Start your day in the Expo Hall with a delicious breakfast and engaging conversations—connect with 50+ innovative organizations driving better results in clinical research.
Signature Series Session
Clinical research is a dynamic field shaped by the people who plan, conduct, and oversee it at every career stage. This engaging panel brings together diverse voices—from early-career professionals to seasoned leaders—to share their career journeys, the leadership skills that fueled their growth, and the pivotal moments that defined their paths.
Panelists will offer insights on:
How they entered and advanced within clinical research
The leadership competencies that made the greatest impact
Lessons learned and practical advice for others shaping their careers
What keeps them motivated and passionate in an evolving field
Whether you’re just starting out or guiding the next generation, this conversation will highlight the resilience, leadership, and sense of purpose that drive long-term success. Attendees will leave with fresh perspectives, actionable guidance, and renewed inspiration to chart their own path, make meaningful contributions, and thrive in a field that is constantly evolving.
CEU: 1.00 ACRP
Speakers coming soon!
The Careers in Clinical Research (C-CLEAR) Program is an eight-week immersive summer experience designed to introduce undergraduate students to careers in oncology clinical trials. Hosted by the University of Kansas Cancer Center's Clinical Trials Office, the program provides hands-on exposure to core research functions including informed consent, protocol navigation, adverse event reporting, regulatory documentation, and data entry. Students complete Good Clinical Practice (GCP) training and gain real-world experience through shadowing across multiple departments, including time with oncologists in the Phase One Clinic. The program also emphasizes professional development through mentorship, résumé building, and final presentations to research staff. This session will present a practical and replicable model for building early-career pathways into clinical research. Attendees will receive tools, strategies, and lessons learned to support workforce training and sustainable pipeline development in academic research settings.
CEU: 1.00 ACRP
Speaker:
Joseph Hines II, MPH, Executive Director, Research Operations-Clinical Trial Office, University of Kansas Cancer Center
In response to growing pressures from federal sponsors to demonstrate efficient research oversight, the Penn State College of Medicine undertook a strategic reorganization of clinical research monitoring and auditing services. This effort involved centralizing monitors from multiple units and realigning an auditor into our human research quality assurance office. A scalable chargeback model was developed to support this new structure, financial stewardship, and risk-based workload allocation. Attendees will learn how institutions can transition from siloed, grant-dependent quality functions to a centralized model that is both cost-recoverable and operationally sustainable. They will learn how to evaluate capacity, align oversight with risk profiles, and design a flexible fee structure based on study complexity and enrollment. The session explores how the reorganization positions the institution to adapt to the evolving expectations around indirect costs. This presentation provides a practical roadmap for modernizing research oversight by enhancing sustainability, or maximizing value from existing resources.
CEU: 1.00 ACRP
Speaker:
Kevin Gardner, Jr., MS, BSN, RN, CCRC, Director, Clinical Trials Office, Penn State College of Medicine
Are you preparing for ACRP Certification? Join this engaging panel session led by ACRP’s Certification Director and facilitated by ACRP’s Certification Manager. You’ll hear firsthand from three clinical research professionals—including an ACRP Board Member, a dedicated ACRP volunteer, and an active ACRP Member—who have successfully earned their ACRP Certification. Panelists will share their unique certification journeys, offering insights into how they navigated the application process—from submission to eligibility approval. They’ll discuss the timeline, what to expect during the review, and how they prepared for the exam. Attendees will also learn about different testing modalities and hear practical advice, study strategies, and tips for success directly from those who’ve been through it. Note: This session will not cover exam content.
This session does not provide ACRP Contact Hours.
Speakers coming soon!
The emergence of decentralized clinical trials (DCTs) has reshaped the way we approach execution of clinical trials requiring few or no face-to-face touchpoints with patients. A successful DCT requires a different operational infrastructure, different technology, and different personnel from a traditional clinical trial. This session offers a practical, end-to-end toolbox for designing and operationalizing DCTs. Attendees will learn actionable strategies for protocol design that allow remote workflows and patient-centric recruitment. We will discuss common pain points that contribute to attrition in DCTs and strategies for prevention. The session will review approaches for building and leading remote teams and for leveraging technology to improve efficiency of remote work. Finally, we will discuss the role of the principal investigator, research coordinator, and data manager as they are deployed in a decentralized fashion. This talk is for those interested in launching DCTs and for those running DCTs who want to expand their capabilities.
CEU: 1.00 ACRP
Speaker:
Megan Lamberti, Vice President of Clinical and Regulatory Affairs, Nilo Medical Consulting Group
The field of oncology clinical trials is dynamic and intricate, with continuous evolution introducing new challenges for research sites. This panel discussion features seasoned representatives from highly active research sites sharing their innovative strategies for navigating this evolving landscape. While universal solutions are elusive, each site employs a unique blend of technology and human expertise to achieve its research objectives.
CEU: 1.00 ACRP
Speakers:
Michaela Bertram, Clinical Research Manager, Avera Health
Meghan Degele, Sr. Director, Tempus AI
Ashley Servais, Director of Clinical Research, Nebraska Cancer Specialists
Alexis Wilson, Research Clinical Operations Coordinator, MemorialCare
The clinical research enterprise often attracts the kind of perfectionists who feel crushed when they make mistakes. They take failure personally, and, in an industry where every "i" and "t" are quality checked, their shortcomings are always noticed. But, what if we could build a clinical research team that promotes inclusion, learning, expression, and contribution--a team whose members no longer wake up in the night wondering if they forgot a signature during the monitoring visit? This session will promote the values of psychological safety in the workplace, and empower listeners to identify psychological safety principles and the impact on teams that lack them. Participants will be guided through real-life monitoring scenarios, learn what went right or wrong, and practice applying the four stages of psychological safety.
CEU: 1.00 ACRP
Speakers:
Amanda Egan, CCRP, Clinical Research Associate, Merck
Carli Lettrich, Senior Clinical Research Associate, Merck
Kyle Niquette, CCRA, Clinical Research Associate Manager, Merck
Turnover among clinical research professionals increases trial costs, delays timelines, and compromises data quality. Across sponsors, contract research organizations, health systems, and academic sites, workforce instability puts studies—and outcomes—at risk. This session shares a case study from the healthcare sector, where investing in psychological safety through expert-led group coaching led to a 20-point drop in annual turnover and $32 million in annual savings—while improving team performance and engagement. Psychological safety—the belief that team members can speak up and take risks without fear—is a proven driver of retention, operational efficiency, and proactive problem-solving. Group coaching embeds this mindset into team culture, enabling trust, reducing errors, and supporting sustainable performance. Attendees will leave with practical strategies to apply this low-lift, high-impact approach to onboarding, leadership development, and daily operations.
CEU: 1.00 ACRP
Speakers:
Francie Jain, Founder & CEO, Terawatt, Inc.
Tommy Thomas, CEO, Opposite Strengths Licensing, LLC
Research teams are being asked to do more with less—especially when it comes to unfunded or underfunded studies. Whether it’s supporting investigator-initiated trials with no startup budget or absorbing hidden costs from sponsor studies, the financial strain is real. This session offers practical strategies for identifying and managing financial risk at the site level. We’ll walk through tools for feasibility screening, cost recovery, and portfolio-level decision-making. Attendees will leave with insights they can use to engage investigators and institutional leaders in honest conversations about what it really costs to “just get it done.”
CEU: 1.00 ACRP
Speaker:
Shannon Chism, Consultant, Huron Consulting Group
Back by popular demand and reimagined for 2026, the ACRP Game Show returns with more energy, more surprises, and more chances to test your knowledge in this high-energy session. Teams of clinical research professionals will go head-to-head in a fast-paced trivia battle covering everything from ICH-GCP principles to eClinical technology, informed consent essentials, and more!
Audience members won’t just watch—they’ll play along, cheer on their peers, and maybe even walk away with bragging rights. Whether you're a seasoned expert or a curious newcomer, this session is your chance to learn, laugh, and celebrate the clinical research enterprise in a whole new way.
CEU: 1.00 ACRP
Speaker:
Elisa Cascade, MBA, FACRP, Chief Growth Officer, Head of Americas, TrialScreen
Technology rollouts in clinical research struggle when change isn’t managed effectively. This session explores how to lead successful transitions to site-based eClinical solutions like electronic investigator site files, electronic source, and participant engagement platforms. The session will highlight common pitfalls in site-level implementations and how to avoid them through proactive communication, pilot workflows, and leadership alignment. Designed for site leaders and operations professionals, the session focuses on practical, real-world strategies for overcoming resistance, fostering cross-functional buy-in, and building adoption plans that last beyond go-live. Attendees will walk away with a clear framework on how to engage stakeholders early, design training that sticks, and track meaningful adoption metrics.
CEU: 1.00 ACRP
Speakers:
Alicia Gearhart, Director of Professional Services, RealTime eClinical Solutions
Kristen Schoch, Marketing & Events Manager, RealTime eClinical Solutions
U.S. Food and Drug Administration (FDA) inspections can be high-stakes events for clinical research sites, especially within large site networks. Yet, many sites and quality assurance (QA) teams only engage reactively, leading to inconsistent readiness and potential regulatory exposure. This session presents a proactive, collaborative model for ongoing alignment between site operations and the network’s QA function. Through real-world examples and practical tools, we’ll demonstrate how early QA involvement, open communication, and joint preparation foster a culture of continuous inspection readiness. Attendees will leave equipped with actionable strategies for collaborative mock audits, risk-based Corrective and Preventive Action (CAPA) plan implementation, and quality-focused training that empowers staff and mitigates FDA risk.
CEU: 1.00 ACRP
Speakers:
Margaret (Meg) Rood, VP, Operational Excellence, IMA Clinical Research
Andreja Vlajankov-Salaj, Sr. Director, Quality Assurance, IMA Clinical Research
Informed consent is a cornerstone of ethical research, but without accounting for health literacy, it often fails to ensure true participant understanding. This session will explore how research professionals can bridge the gap between regulatory compliance and meaningful comprehension, particularly in sensitive fields like reproductive health. Drawing from real-world experience in Phase III trials, biorepository studies, and community health research, I will share practical strategies for improving the consent process using plain language, teach-back methods, and visual aids. We’ll also examine relevant ICH-GCP guidelines, including the requirement that consent information be presented “in a language understandable to the subject,” and discuss how these principles apply in daily research practice. Attendees will leave with actionable tools to support participant-centered communication and to elevate the informed consent process beyond a signature to a personal, nuanced, and regulatory-compliant conversation that leaves patients feeling empowered in their decision.
CEU: 1.00 ACRP
Speaker:
Gianna Gemignani, BS, ACRP-CP, Clinical Research Project Coordinator, University of Wisconsin-Madison School of Medicine and Public Health (Department of OB/GYN)
Break for lunch and discuss what’s next—connect with your community, share your top takeaways with your peers, and discover solutions from 50+ trailblazing organizations throughout the Expo Hall.
Sites are overwhelmed by the increasing number and complexity of technology solutions required to execute clinical trials. This is exacerbated by the increasing number of solution providers selected. Currently, research sites are typically required to use sponsor-provided technology systems. The Decentralized Trials and Research Alliance's (DTRA's) "Bring Your Own Technology" initiative aims to enable clinical research sites to use their own validated technology systems in industry-sponsored clinical trials while maintaining regulatory compliance and sponsor oversight. The objective is to reduce operational inefficiencies, improve data quality, and enhance site and patient experiences. This session will share the work done by DTRA to date to define a process to enable adoption of site-preferred technology in registrational trials. Using eConsent as a model, key considerations and impact assessments conducted to identify opportunities and challenges from a multi-stakeholder perspective will be shared. The work continues in 2025-26, focusing on site-preferred eSource adoption by sponsors.
CEU: 1.00 ACRP
Speakers:
Joe Dustin, Founder and Principal, Dauntless eClinical Strategies
Rick Greenfield, BBA-IS, Founder & Chief Strategy Officer, RealTime eClinical Solutions
Brandon Maggio, Global Head of Digital Operations & Process Optimization, Glaxo Smith Kline
Jane Myles, Program Director, Decentralized Trials and Research Alliance
Study startup delays represent a critical barrier impairing efficiency in clinical research timelines and our ability to ultimately serve patients. Tackling each contributing factor in this issue should be an effort we all engage in. The Site-Sponsor Consortium—a unique collaboration of sponsors, contract research organizations, institutional sites, and commercial sites—will unveil its inaugural whitepaper, which details actionable strategies to simplify and harmonize Confidentiality Disclosure Agreement processes across the industry. Consortium members will discuss the operational and ethical imperatives for reform, the value of master and bilateral agreements, and the collaborative journey that led to consensus-driven solutions. Attendees will gain insight into the practical steps needed to reduce study startup timelines and foster a culture of shared responsibility, transparency, and innovation in clinical research.
CEU: 1.00 ACRP
Speaker:
Christine Senn, PhD, CCRC, CPI, FACRP, SVP, Site-Sponsor Innovation, Advarra
Clinical research can be made more trustworthy and accessible by engaging communities through unconditional, literacy-driven outreach. This session shares a model for engaging people where they are, not as future participants or workforce members, but as community members deserving of clarity, inclusion, and respect. Presenters will share examples of how they deliver plain-language education about clinical research, facilitate conversations around research mistrust, and equip communities with the tools to navigate research information and options. These efforts aren’t tied to active studies or enrollment; rather, they’re grounded in the belief that long-term public trust is built through repeated, agenda-free education. Attendees will walk away with replicable strategies for building community-facing literacy initiatives centered on equity, transparency, and relationship-building.
CEU: 1.00 ACRP
Speakers:
Addison Gumbert, Founder, Premier Clinical Marketing
Mitchell Hilbe, CEO / Co-Founder, DiversiTrials
The relationship between clinical research coordinators and monitors is at the heart of every trial. Too often, it is defined by miscommunication, mistrust, and turf wars, but clinical trials move too quickly and are too important to allow these avoidable barriers to persist. This interactive session, led by monitors who were once coordinators, flips the script. With a unique dual perspective of site and sponsor, the speakers explore how empathy, communication, and perspective-taking can transform this critical relationship from adversarial to collaborative. Attendees will gain heightened self-awareness and actionable strategies for their unique situations. When coordinators and monitors work in sync, clinical trials run smoothly. Let's rethink the status quo and co-create a culture of mutual respect and shared goals--because better relationships mean better research.
CEU: 1.00 ACRP
Speakers:
Jodie Addington, Senior Specialist, Clinical Research Monitoring, Edwards Lifesciences
Kelly Chan, BS, CCRA, Manager, Clinical Research Monitoring, Edwards Lifesciences
Misty Daniel, CCRC, CCRA, Senior Specialist, Clinical Research Monitoring, Edwards Lifesciences
Does working with your IRB feel like a roadblock? With the right strategies, you can develop a powerful partnership to ensure ethical, efficient, and compliant research.
In this session, participants will learn how to communicate with the IRB in ways that reduce delays, improve protocol clarity, and support ethical decision-making. Grounded in real-world IRB review practices, federal regulations (45 CFR 46), and institutional experience, we’ll explore what the IRB actually prioritizes in a protocol submission and how to deliver a clear and concise submission for review.
We’ll cover how to describe study activities in a way that aligns with regulatory criteria, write protocols with clarity around data handling, participant interactions, and multi-site coordination, and navigate pushback or differing IRB interpretations. Whether you’re managing a straightforward survey study or a complex, multi-site data integration project, this session will equip you with strategies to make your IRB submissions more efficient and effective.
CEU: 1.00 ACRP
Speakers:
Marianna Azar, Director, Human Research Protection Program, Research Foundation for Mental Hygiene (New York State Psychiatric Institute)
Challace Pahlevan-Ibrekic, Director, Clinical Research, Northwell Health
What if the real obstacle to better recruitment isn’t your budget or your systems... but how you communicate? Too often, clinical teams overlook the role personality plays in how messages are delivered, received, and acted on in both internal departments and patient communications. And believe or not, they coorelate more than you think.
This session explores how internal misalignment in communication can spill over into patient-facing interactions, impacting trust and clarity (and ultimately recruitment & retention). Using personality test frameworks like DISC, MBTI, and others, we’ll explore our own communication preferences, categorize communication styles of others, and how to adjust your approach to build stronger connections. When applied to patient recruitment, strong communication builds greater trust with patients by showing an understanding of who they are, their priorities, and how they communicate. When patients feel understood, you earn their trust.
When communication flows, recruitment follows.
CEU: 1.00 ACRP
Speaker:
Addison Gumbert, Founder, Premier Clinical Marketing
This session will discuss the implementation a novel tool for Identifying IRB Review Level for Studies involving Secondary Use of Data/Specimens.
CEU: 1.00 ACRP
Speaker:
Leslie Bell, Regulatory Specialist, Medical University of South Carolina-South Carolina Clinical and Translational Research Institute (SCTR)
Discover how prioritizing soft or aligned skills in hiring and training entry-level clinical research professionals can open sustainable pathways to success—and learn how to put skills-based hiring into action at your institution. We’ll briefly examine industry trends and the importance of a sustainable talent pipeline with the right skills. We will share our real-life experiences building a workforce development program, and provide tools for screening, hiring, and developing the desired soft skills. Participants will reflect on their own institutional needs and practices, and come away with actionable strategies to create inclusive, skills-based paths into the profession. By revisiting the Joint Task Force for Clinical Trial Competency model through the lens of your institution’s prioritized soft skills, you’ll assess alignment, identify gaps, and explore ways to refine expectations—ensuring your training goals and performance benchmarks are appropriate and personalized.
CEU: 1.00 ACRP
Speaker:
Kathleen OMalley, BSN, CCRP, Director of Education and Training, Jefferson Clinical Research Institute, Jefferson
Delays in clinical trial budgeting often result not from lack of effort, but from a lack of shared understanding across stakeholders. Sites, sponsors, and contract research organizations each have different processes and constraints that create friction in this critical startup process. This session presents findings from a cross-industry working group that explored the root causes of budgeting misalignment and developed practical, stakeholder-informed strategies to close the gap. The group’s work centers on three key domains—study startup operations, budget estimation, and budget justification—and shares insights from real-world experiences across the research ecosystem. The goal is to accelerate study startup by building mutual understanding, streamlining communication, and promoting efficient negotiation. Attendees will walk away with actionable tools that can be used to upskill staff, improve cross-functional collaboration, and support an improved approach to budgeting in clinical research.
CEU: 1.00 ACRP
Speakers:
Candida Barlow, PhD, MSN, CRN-BC, RN, Director Clinical Research, Oklahoma State University Center for Health Sciences
Andrea Bastek, Ph.D., VP of Market Strategy, Florence Healthcare
Clinical trial recruitment faces persistent challenges, including prolonged enrollment periods, high screen failure rates, and inconsistent data quality. This session introduces the innovative block enrollment strategy, which accelerates trial recruitment by concentrating all site resources on a single protocol during a focused enrollment period. By aligning the entire research team and optimizing patient engagement, the block enrollment approach improves enrollment efficiency, reduces screen failures, and enhances participant retention. Drawing on real-world data from ophthalmic trials, attendees will explore how this model streamlines workflows while maintaining rigorous quality standards. The session will engage participants in discussing scalability and adaptation of block enrollment across various therapeutic areas. Key roles of principal investigators, study coordinators, and support staff in this focused recruitment method will be highlighted. Attendees will have the opportunity to learn about a transformative, practical approach that reshapes clinical trial enrollment and optimizes site performance.
CEU: 1.00 ACRP
Speaker:
David Almeida, MD, MBA, PhD, President and CEO, Centers for Advanced Surgical Exploration (CASEx) and Erie Retina Research
Decentralized clinical trials are reshaping how research is conducted, offering new opportunities to expand access, improve participant accrual, and reduce the burden on limited organizational resources. This session will explore transformative approaches institutions can take to implement and manage decentralized trials effectively. Attendees will learn how to adopt flexible models that support research growth without requiring extensive staffing or infrastructure. The session will highlight practical strategies for integrating decentralized elements into existing workflows, including virtual visits, digital tools, and participant-centered processes. Real-world examples will show how organizations have successfully used decentralized models to reach underserved populations and streamline operations. Whether the organization is beginning to explore decentralized research or looking to scale existing efforts, this session will provide actionable insights to help align trial design with institutional goals. Attendees will discover how decentralized research can be a powerful tool for increasing efficiency, expanding reach, and supporting sustainable research operations.
CEU: 1.00 ACRP
Speaker:
Shreya Singh, Consulting Sr. Associate, Huron Consulting Group
This session proposes a new operational paradigm focused on redesigning the internal structure of clinical trial sites through the incorporation of specialized roles--with active support from the industry--to ensure quality, efficiency, and long-term sustainability. The presenter will analyze the structural limitations of the traditional site model and their implications for quality, compliance, and efficiency; demonstrate the strategic value of new key roles such as clinical trial managers, quality control specialists, quality assurance specialists, clinical trial educators, and clinical research coordinator assistants; present a scalable framework based on quality management systems (QMS) that integrates these roles; and offer an action plan to transform site structures and strengthen the workforce.
CEU: 1.00 ACRP
Speaker:
Carlos Pinoargote, Chief Operating Officer, BRCR Global
Learn a values-based framework to standardize budgets while honoring site needs, empowering advocacy, equity, and site sustainability.
CEU: 1.00 ACRP
Speaker:
LaTisha Weaver, Consultant - CEO, LDM Clinical Research Source
Many early-career clinical research professionals are thrust into complex, fast-paced project environments with limited exposure to formal project management training. This session provides a practical introduction to core project management principles tailored to clinical research settings—specifically at the study and site level. Attendees will explore key tools and strategies for managing timelines, tracking milestones, handling communications, and identifying potential risks before they become problems. Real-world case examples will highlight how applying simple project management frameworks can reduce study delays, improve team coordination, and support operational success. This session will be especially valuable for site coordinators, study managers, and new team leads looking to enhance their organizational skills and confidence in managing day-to-day research operations.
CEU: 1.00 ACRP
Speaker:
Cassidy Chester, Clinical Research Coordinator, University of Utah
This session explores how to celebrate Gen Z colleagues, collaborate effectively with Millennial bosses, and embrace the strengths of a multigenerational workforce. Today’s organizations face new challenges as employees bring diverse values, attitudes, and expectations. Baby Boomers represent 15% of the workforce, Gen X 31%, Millennials 36%, and Gen Z 18%.
Participants will learn to identify and compare generational core values and cultural influences to enhance communication and build high-performing, inclusive teams. The session highlights recognizing personal biases and avoiding snap judgments about other generations.
A key focus is the paradigm shift from a traditional “boss” mentality to a “coach” approach, fostering trust and engagement across age groups.
In the clinical research community, where collaboration is critical, each generation contributes unique strengths and perspectives. This session equips attendees to support intentional cross-generational communication, encourage mutual understanding, and leverage diversity to strengthen teamwork and improve outcomes in this dynamic environment.
CEU: 1.00 ACRP
Speakers:
Yekatrina Tsabur, Organizational Consultant, Sophos
Yelena Tsabur, Organizational Consultant, Sophos
This session will highlight the transformation of protocol activation and lifecycle management that results in improved research billing compliance, streamlined workflows, aligned financial policies, and enhanced training curriculum. Despite the complexity of study activation, we found that mastering the basics—clear policies and procedures along with practical tools—was key to success. Attendees will leave with strategies and tools to confidently support clinical trial workflow transformation projects.
CEU: 1.00 ACRP
Speakers:
Chad Eriksen, MS, CCRC, FACRP, President, Strategic Advisor / Sr. Project Manager – Yale Center for Clinical Investigation (YCCI) Iron Horse Research
Kayleen Joyce, MS, CCRC, ACRP-PM, Consulting Manager, Huron Consulting Group
The question of how—and how much—to compensate research participants is far from settled. While undue influence remains a central concern, too little compensation can be equally problematic—failing to respect participants’ time, reinforcing inequities, and limiting recruitment from underrepresented groups. What truly constitutes "undue influence"? Should compensation only reflect time and inconvenience, or also acknowledge risk? Do higher payments undermine voluntariness, or do they simply acknowledge the realities of participation? This session will examine current debates alongside emerging trends, including reimbursement versus compensation, digital wallet payments, gamification, and punitive terms of payment. Drawing on ethical frameworks, regulatory guidance, and real-world case examples, we will provide attendees with practical tools to evaluate and justify compensation strategies that withstand scrutiny while supporting participant trust and engagement.
CEU: 1.00 ACRP
Speaker:
Robert Romanchuk, CIP, BSHS, Chairperson, Regulatory Director, Univo IRB
Connect with your colleagues and 50+ leading-edge organizations and suppliers helping you get better results in clinical research.
Relax and unwind with a beverage and light hors d'oeuvres in the Expo Hall.
Training challenges persist throughout the clinical research enterprise. This session presents benchmark data and discusses practical solutions for partnerships between sponsors, contract research organizations, and sites to address site-based training shortcomings for the betterment of clinical trial conduct.
CEU: 1.00 ACRP
Speaker:
Jimmy Bechtel, Vice President, Site Engagement, SCRS
Payment for services in the healthcare industry is handled unlike the payment process for any other business. Learn the different models by which investigators can be compensated; the basics of the Anti-Kickback Statute, the False Claims Act, and the Stark Law; how they govern investigator payment; and the average per-patient investigator compensation by trial type. The speaker will share one hospital’s experience with successfully compensating physicians based on the various types of medical groups and hospital physicians they contract with. In this session, attendees can be prepared to learn about managing investigator payments; creating compensation that is fair, motivational, affordable, practical, legal, and agreeable; and motivating investigators without incentivizing them to perform clinical trials.
CEU: 1.00 ACRP
Speaker:
Suzanne Rose, MS, PhD, Executive Director of Research, Stamford Hospital
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
Leveraging electronic tools is essential for maintaining inspection readiness in today's regulatory landscape. Paper-based methods are cumbersome and time-consuming, and they create logistical challenges in record keeping. In contrast, technology offers centralized record keeping, and electronic file storage is now both cost-effective and user-friendly. This shift is underscored by updated guidelines such as ICH E6(R3), which promotes media neutrality, flexibility, innovation, proactive quality, and robust data governance. Additionally, remote regulatory assessments, which were proven effective during the pandemic, enhance efficiency, flexibility, and global reach while reducing travel and disruption. Despite these advancements, recent feedback from regulators indicates a regression in the adoption of these technological tools. It is time for sponsors to embrace risk proportionality, which is supported by regulatory authorities, to maintain inspection readiness.
CEU: 1.00 ACRP
Speaker:
Marc Wartenberger, CQA, CTFL, Senior Director, Security, Corporate QA & Compliance, CRIO
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
The U.S. Food and Drug Administration's (FDA’s) recent guidance for institutional review boards on informed consent was the first update to the old “information sheets” on the topic in nearly 20 years. The Office for Human Research Protections beat FDA to the punch with new consent form requirements, but does the latest guidance mean there is a new “reasonable person” in the room? In this session, we will break down the new FDA guidance and what it means for accredited Human Research Protection Programs. Some organizations may not need to make any extensive changes, but there are differences between the FDA guidance and the expectations of the Common Rule concerning informed consent that must be considered.
CEU: 1.00 ACRP
Speaker:
James Riddle, MCSE, CIP, CPIA, CRQM, SVP Global Review Operations, Advarra
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Research team retention and engagement heavily impacts enrollment and program performance. Join Michelle Rowe from HCA Healthcare Research Institute, as she leads a discussion on talent retention, onboarding, and colleague development. During the panel discussion attendees will hear from HCA Healthcare leaders from Site Operations, Quality & Compliance, Strategic Projects, and Human Resources on the important challenges facing programs today and practical and effective pathways forward. Leave the discussion with knowledge on approaches to onboarding across over 43 sites of care with a core belief that HCA Healthcare's greatest strength is its talent. Discover practical strategies to standardize talent retention by making actionable ownership of colleague development an intrinsic part of the culture of your program.
This session does not provide ACRP Contact Hours.
Speakers:
Andrea Berkovsky, Director of HR, HCA Healthcare Research Institute
Lauren Horton, PhD, Director of Research, North Texas Division, HCA Healthcare Research Institute
Sybil Hyatt, MBA, RN, AVP Site Operations, HCA Healthcare Research Institute
Michelle Rowe, RN, VP, Research Institute, HCA Healthcare Research Institute
Robbin Seago, AVP Research Ethics & Compliance, HCA Healthcare Research Institute
This session is sponsored by
In this session, an expert panel with members representing a top 10 industry sponsor; a research and policy center; an independent nonprofit organization; and a pharmaceutical business intelligence provider will share actionable insights on expanding the scope of diversity in clinical trials. The panelists will elaborate on the section of the new U.S. Food and Drug Administration (FDA) diversity plan guidance stating that "FDA advises sponsors to seek diversity in clinical trial enrollment beyond populations defined by race and ethnicity, including other underrepresented populations defined by demographics.”
CEU: 1.00 ACRP
Speakers:
Sylvia Baedorf Kassis, MPH, Program Director, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
Behtash Bahador (he/him), Director of Health Literacy, Center For Info & Study on Clinical Research Participation (CISCRP)
Fenwick Eckhardt, Head of Diversity Strategy, Citeline
Meghan McKenzie, MA, Director of Health Equity and Clinical Research, Genentech's Chief Diversity Office
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
The session will focus on various types of protocol designs and changes, with an emphasis on adaptive designs. We will review the FDA guidance on “Adaptive Designs for Clinical Trials of Drugs and Biologics.” Taking a deeper dive into unplanned design changes and regulatory considerations, we will engage in one of the oldest thought experiments in Western philosophy, the Ship of Theseus, to address an ambiguity in clinical trial design. Here, we will consider alternative ways protocols are commonly modified, and whether those changes could be considered an entirely new clinical trial, rather than a modification. This session will also provide an educational background in trial design for professionals who haven't had as much exposure to the topic as they wish, and will include a detailed review of sections of ICH E8(R1) and ICH E6(R2), where they relate to trial design.
CEU: 1.00 ACRP
Speaker:
Amanda Egan, Associate Clinical Research Associate, Merck
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
In this session, we will dive into the history of women leadership and discuss barriers women face in clinical research leadership positions. What is the leadership landscape in clinical research and how can you be an effective leader in it? Let’s create a Blank Space and level the playing field by breaking those barriers. How will we do this? By embracing a journey of change, being fearless, and mastering the strategies necessary for overcoming barriers as a female leader and achieving success.
CEU: 1.00 ACRP
Speaker:
Jessica Fritter, DHSc, MACPR, ACRP-CP, Associate Clinical Professor, The Ohio State University
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Leadership & Professionalism Journey Sponsor
Signature Series Session
Meaningful change can come from the top down and the ground up—but in clinical research, valuable perspectives from seasoned professionals in the field have been silent for too long. This session builds on an NIH survey that was first examined at ACRP 2024 and then expanded upon in a pioneering national survey by ACRP and Continuum Clinical in December 2024 with the goal of understanding how to improve clinical trials from those who implement and manage trials.
Through the lens of transformation, this survey goes beyond the barriers that are typically captured to explore real-world actionable insights for clinical trial implementation, our current state, where do we want to go from here, and the changes needed to reach an ideal future state.
Come hear wisdom gathered from clinical research professionals just like yourself--and share your voice in this lively discussion! Our speakers will share the survey insights and propose practical, solutions-based approaches to overcome the reported barriers. All ACRP 2025 registrants will receive exclusive access to a pre-read document before the conference to help set the stage for the discussion in New Orleans.
Join us for this engaging session to discover actionable solutions to the issues that hinder successful clinical trials. Your colleagues (and hopefully, you!) have spoken, so don't miss out!
CEU: 1.00 ACRP
Speakers:
Jeri Burr, MS, RN, PED-BC, CCRC, FACRP, Program Director, University of Utah
Paul Ivsin, Executive Vice President, Trial Engagement Service, Continuum Clinical
Edwina McNeill-Simaan, EdD, MSHS, CCRC, CCRP, Program Director, Vanderbilt University Medical Center
Nancy Sacco, PhD, VP Head of Clinical and Site Development Operations, SiteBridge Research Inc
Jennifer Sheller, Senior Vice President, Head of Global Clinical Trial Operations, Merck
Pamela Tenaerts, MD, Chief Scientific Officer, Medable
Leadership & Professionalism Journey Sponsor
Explore innovative ideas, research findings, and best practices in clinical research through our engaging poster presentations, displayed in the Expo Hall during open hours. Educational posters are visual summaries designed to present key information in a clear, concise, and compelling way. They allow researchers and professionals to share their work, spark discussions, and inspire new approaches to clinical research challenges.
Authors will be available for in-person Q&A at 1:30 PM on Friday and Saturday. Winners will be announced during the Saturday Networking Reception. We encourage attendees to stop by, view the posters, and engage with the presenters to deepen their understanding of the projects and connect with peers.
Posters:
Biospecimen Collection: The Cornerstone of Clinical Trials
Authors: Kay Murphy, Halley Losekamp
Building Research Capacity and Advancing Equity in Community Oncology Clinical Trials: A Pilot Training Program
Authors: Kimberly Demirhan, Sumanta Pal, Latha Shivakumar, Molly Kisiel, Elana Plotkin
Ghosting? More than a Dating Trend
Author: Leah Orozco
How to Be Your Own Internal Study Monitor
Author: Ann-Marie Jacobson
It’s Not you, It’s me. Where do we go now?
Author: Estela Staggs
Patient-Centered Consent: Bridging Trust in Clinical Research
Authors: Megan Rodgers, Andrea Gutierrez
Pediatric Site Response to Rapid Implementation of Decentralized Clinical Trials (DCTs)
Author: Abigail Kietzman
Site-Enabled Decentralized Clinical Trial Model for Rare Diseases
Authors: Alpa Khushalani, Amy Chestnut
Understanding the Role of CROs and Sponsors During the Feasibility Process to Increase Enrollment for Racial and Ethnic Minorities in Clinical Trials
Author: Jalen Denson
Recent discussions around diversity and inclusion have highlighted the limited participation of Americans in clinical research, with only 10 to 20 million out of 320 million involved. Many solutions, like decentralized clinical trials, focus on making participation easier for those already involved rather than reaching new participants. In my presentation, I will showcase initiatives and technologies aimed at recruiting those not yet participating in clinical studies, stressing that inspiration and education are key to growing the pool of engaged populations.
CEU: 1.00 ACRP
Speaker:
James Morton, PharmD, Adjunct Professor, UC San Diego Extended Studies
Watch a Sneak Peek into the Session Content:
Patient recruitment remains a significant challenge in our industry, often exacerbated by outdated U.S. Food and Drug Adinistration guidelines. Despite these constraints, there are ways to improve recruitment through better advertising practices. This panel brings together perspectives from sponsors/contract research organizations (CROs), institutional review boards (IRBs), and sites to discuss best practices within their organizations and how to form effective, mutually beneficial partnerships. We will focus on how sites and sponsors/CROs can implement winning strategies in patient recruitment advertising that also meet IRB review expectations. Each organization will offer actionable insights aimed at enhancing their processes to improve recruitment outcomes.
CEU: 1.00 ACRP
Speakers:
Meghan Joseph, Site Engagement, Patient Recruitment & Retention, Moderna
Matthew Maxwell, Chief Growth Officer, Centricity Research
Jason Rush, BS, CIP, Senior Director, Regulatory, Advarra
Christine Senn, PhD, CCRC, CPI, FACRP, SVP, Site-Sponsor Innovation, Advarra
Related Blog Content:
Study & Site Management Journey Sponsor
An estimated 20% to 50% of trial protocols launched at sites will eventually close without a single enrolled participant, wasting considerable resources along the way. While not mandated, feasibility reviews are being utilized by many organizations to minimize the risk of opening studies that ultimately will fail. Stage-gate process, a framework described in industrial organization management, can help identify projects early that are likely not to succeed and stop them before extensive resources are invested, freeing those resources to support other projects more likely to succeed. The feasibility process should include review of a diverse array of resources--financial, human, and physical--as well as the ability to accrue needed participants. This presentation will discuss the stage-gate framework, provide tips on processes that can be used to implement a feasibility process, and offer metrics and data organizations can use to drive the analysis empirically.
CEU: 1.00 ACRP
Speaker:
Wendy Tate, PhD, MS, Product Strategy Senior Director, Advarra
Related Blog Content:
Watch a Sneak Peek of the Session Content:
Study & Site Management Journey Sponsor
Understanding that site management organizations (SMOs) are essentially the bridge between the sponsor/contract research organization (CRO) and sites, we will demonstrate proven quality improvement practices used by SMOs to reduce start-up timelines. Roles discussed involve study activation, regulatory compliance, contracting and budgeting, clinical education, and clinical trial management system oversight. Participants will understand the function of each role and how the delineation of responsibilities improves site compliance, data quality, and sponsor/CRO satisfaction with a site's clinical trials. We will explore best practices using specific examples from real-world experiences, including technology use and templates covering communication, trial management, study and site specifics, etc.
CEU: 1.00 ACRP
Speakers:
Charita Braker, Manager, Clinical Research Education, HCA Healthcare Research Institute
Jessi Klindedinst, Manager, Regulatory Affairs, HCA Healthcare Research Institute
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
Translational research is often driven by independent physician-investigators who want to bring medical innovations to the bedside. These pioneers take on the design, implementation, and compliance needs of their clinical trials, often without any formal training on research methodology. Similarly, lack of formal regulatory training creates challenges for busy investigators balancing their clinical and research responsibilities, and can put institutions at an increased risk of non-compliance, loss of reputation, and liability. Establishing an investigator-initiated research program (IIRP) can address the knowledge gap, foster translational research, and provide a support model that improves the quality of research, enhances reproducibility of results, and ensures compliance while protecting the rights of and maximizing the potential benefits for research participants. The session will focus on the importance of an IIRP regardless of research portfolio size, will deliver scalable steps for success. The example of a bottom-up approach will provide a framework for discussion and opportunity to share lessons learned.
CEU: 1.00 ACRP
Speakers:
Pamela Cooper, Manager, Investigator Initiated Research Program, Hackensack Meridian Health Inc
Elli Gourna Paleoudis, PhD, Director, Investigator Initiated Research Program and Support Services, Hackensack Meridian Health
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
In a post-pandemic landscape, learning, conducting, and implementing clinical trials significantly changed with the adoption of globally accepted decentralized methods. Variability across educational offerings may not assess learner competency to perform clinical research operational activities. In this panel, clinical investigators, a U.S. Food and Drug Administration representative, and educators will explore varied modalities for training investigators and consider avenues for comprehension in terms of learning on the job, through structured courses, by attending sponsor/contract research organization-conducted trainings, or by completing online modules--none of which may be sufficient in isolation. Fundamentals of online teaching and learning, coupled with adult learning methods and the industry's continued reliance on a "decentralized method of training," are pivotal to assess learner capability. In the absence of documented analysis and evaluation of the effectiveness of micro-credentials, presenters will discuss strengths/weaknesses, gaps, and challenges of the biopharmaceutical industry's reliance on the current modes of training and education of clinical research professionals.
CEU: 1.00 ACRP
Speakers:
Nadina Jose, MD, Assistant Professor, School of Health Profession, Rutgers, The State University of New Jersey
Anita Kablinger, MD, CPI, FAAP, FAPA, FACRP, FASCP, Professor, Academic Vice Chair and Director of Clinical Research, Department of Psychiatry and Behavioral Medicine, Virginia Tech Carilion School of Medicine, Virginia Tech Faculty of Health Sciences
Erika Stevens, MA, FACRP, Director, Research Experience, Rutgers
Watch a Sneak Peek into the Session Content:
In this session, we will examine barriers impeding effective decision-making and critical thinking in clinical research, including cognitive biases and information overload, and provide tips and scientifically based tools to help study team members navigate difficult decisions. Criteria for fostering a positive decision-making environment, emphasizing transparency and open communication, will also be examined. Attendees will engage in a thorough analysis of the deductive and inductive reasoning processes inherent to clinical research decision-making. By session's end, participants will emerge armed with empirically grounded strategies to navigate complexity, cultivate critical thinking, and drive impactful outcomes in their clinical research endeavors.
CEU: 1.00 ACRP
Speakers:
Ashley Bader, Clinical Research Nurse Manager, Tampa General Hospital
Alecia Sorrells, MS, BSN, RN, Clinical Research Nurse, Tampa General Hospital
Related Blog Content
Leadership & Professionalism Journey Sponsor
Site-centric recruitment models powered by data and innovation are proving to be successful when two criteria are met--they reduce the burden on the site and they reach the patient closer to home. From "just-in-time" practices to decentralized clinical trials, this session will explore different recruitment models from the perspectives of experts who have successfully managed these approaches--both from the site and sponsor sides. Attendees will walk away with details and examples that they can apply to their efforts in clinical trial recruitment.
CEU: 1.00 ACRP
Speakers:
Noelle Gaskill, MBA, ACRP-CP, VP, GM of Time Network, Tempus
Karla Polk, Clinical Research Executive
Study & Site Management Journey Sponsor
The future is here, and new technology available for investigational product (IP) management opens up a wide range of opportunities. In this session, we will provide an introduction to new IP temperature monitoring capabilities, cold chain innovation, digital automation, predictive analytics, and sustainable technologies that have the potential to enable enhanced quality and improve efficiency. We will also look at how new technologies at both the site and sponsor levels may support patient access to clinical trials and improve compliance with the tenets of ICH Good Clinical Practice.
CEU: 1.00 ACRP
Speakers:
Liza Hill, BS, ACRP-CP, ACRP-PM, Associate Director, Clinical Operations - Clinical Research Manager, Infectious Disease (US), Merck
Mary Williams, Associate Director, Clinical Operations, Merck
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Study & Site Management Journey Sponsor
It seems as if everyone has their own way of designing case report forms (CRFs). For study coordinators, this can mean encountering new expectations (good, bad, or indifferent) from study to study, as well as the same things (truly necessary or not) across many studies. There's always a bit of copying and pasting happening, too, in the hope that lessons learned from prior studies will guide the development of future CRF content. But what if you could have a fail-proof process to ensure that the first draft of a CRF had 95% of the critical variables needed? Find out how using a statistics-driven approach can simplify CRF design. Cut out the noise by removing onerous and non-applicable checklist variables and focusing on only adding analyzable fields that make every single variable useful. During this talk, a research coordinator-turned-clinical research associate will also provide insight into how they contribute to the review process to ensure study flow at the site is taken into consideration.
CEU: 1.00 ACRP
Speakers:
Anna Rillo, BSN, RN, Study Director, Bright Research
Robin Solinsky, BS, VP, Technology & Innovation, Bright Research
Watch a Sneak Peek into the Session Content:
Community outreach remains the industry standard for patient recruitment in minoritized (and majority) communities. Defined as one-way communication, community outreach is often a transactional process that doesn’t typically leave room for bridging the gap between opportunity and community. While outreach may be necessary in some cases, we must begin to make a conscious shift toward engagement through true community partnerships for more equitable access and outcomes. This session is for those hoping to dive deep into community engagement planning and implementation for their organization. Attendees will come away with a new understanding of the pivotal role our communities play in shaping a more equitable and inclusive clinical trial landscape, and tools for deploying impactful and sustainable community engagement plans.
CEU: 1.00 ACRP
Speaker:
Ashley Moultrie, CCRP, Associate Director, Clinical Trial Diversity, Syneos Health
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
The landscape of clinical trial design, conduct, and regulation continues to shift thanks to the rapid infusion of technology and an increased emphasis on inclusion and access. As a result, the U.S. Food and Drug Administration (FDA) and Congress are reevaluating their stances in a number of areas in order to further speed the path to healthcare innovation. However, these changes in policy can present operational challenges for sites and sponsors in the day-to-day management of trials and patient care. This session will run through the latest guidance changes and what they mean for sites and sponsors in 2025. Areas of focus will be the updated guidance on informed consent, diversity action plans, digital health technologies, decentralized clinical trials and Form FDA 1572 reform, use of real-world evidence, and changes to the FDA's Bioresearch Monitoring Program inspection processes. Additionally, the speakers will address the final ruling on taxing patient stipends, the Inflation Reduction Act, and the Food and Drug Omnibus Reform Act of 2022's mandate for innovation.
CEU: 1.00 ACRP
Speakers:
Catherine Gregor, MBA, CCRP, CCRC, Chief Clinical Trial Officer, Florence Healthcare
Sophia McLeod, Advocacy Advisor, Association of Clinical Research Organizations (ACRO)
Related Blog Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Study & Site Management Journey Sponsor
Signature Series Session
ICH E6 changes are upon us. Are you ready to implement new expectations for Good Clinical Practice (GCP) and a flexible framework for clinical trial design and conduct? Please join us for a panel discussion on the principles described within ICH E6(R3), the changes from ICH E6(R2), the implications for GCP, considerations for implementation, and insights on how we as an industry can think through flexible design in a quality-minded environment. This is a session you will not want to miss.
CEU: 1.00 ACRP
Speaker:
Kassa Ayalew, MD, MPH, Director, Division of Clinical Compliance Evaluation, Office of Scientific Investigation, Center for Drug Evaluation and Research (CDER), U.S. Food & Drug Administration (FDA)
Jessica Fritter, DHSc, MACPR, ACRP-CP, Associate Clinical Professor, The Ohio State University
Katherine Mary Marangio, Learning Program Consultant, Parexel Academy
Leslie Sam, BA, CSSBB, CQIA, President, Leslie Sam and Associates, LLC
Watch the Webinar Replay Ahead of the Live Session (Free Without Contact Hours):
Related Blog Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Signature Series Session
Due to speaker unavailability, this session has been cancelled.
Join Dr. David Burrow from FDA's Center for Drug Evaluation and Research as he explores operational strategies for implementing Quality by Design and the integration of Risk Based Quality Management Systems into routine trial design and conduct. Dr. Burrow will build on the key themes discussed in his 2024 Signature Series presentation titled, “Reimagining Clinical Research: The Transformation of Trial Design & Conduct” and bring his own unique perspectives to the next stage of reimagining clinical research and removing barriers to innovation. Take away practical approaches to mitigating obstacles, advancing the shared interests of human subject protection, generating high quality evidence of safety and effectiveness, and enabling action through strategies to manage fear - both as an organization and as an individual.
Objectives:
Discuss key themes of Quality by Design, Critical to Quality factors, and Risk Based Quality Management Systems.
Advance shared understanding of the CDER Center for Clinical Trial Innovation (C3TI) and other FDA drug development programs.
Provide strategies to advance innovation and enhance quality while also minimizing fear of regulatory oversight.
CEU: 1.00 ACRP
Speaker:
David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Join us in the Expo Hall for networking with exhibitors and fellow clinical research professionals! Enjoy meals and connection opportunities throughout the day:
Breakfast: 8:00 – 9:00 AM
Networking & Exhibits: 8:00 AM – 2:00 PM
Lunch: 12:45 – 1:45 PM
Networking Reception: 4:30 – 6:00 PM
Visit the HCA Healthcare Headshot Studio during the times below for a complimentary professional headshot!
8:00 – 10:30 AM
12:00 – 2:00 PM
4:30 – 6:00 PM
Join us for breakfast while connecting with 100+ leading-edge organizations and suppliers helping you get better results in clinical research.
Join us for a guided meditation and breathwork session at ACRP 2025. This session is brought to ACRP 2025 attendees by the ACRP Gulf States Chapter and will be facilitated by Marjorie Pokorny of Turtle Yoga, a local studio.
Space is limited–please RSVP.
About the faciliator:
Marjorie Pokorny is a 500RYT with certification in Hatha, Yin, Chair, and Restorative Yoga. After a lifetime of personal practice, she started teaching after retirement in order to share yoga practice with others. Turtle Yoga, located in New Orleans, opened in 2020 as a donation based, community focused studio. Marjorie is also a trained medicine woman, sound healer, crystal healer, reiki master, and spiritual mentor.
When you arrive in New Orleans, make your way to the registration area to receive your conference badge and essential materials, ensuring you're fully equipped for four days of engaging education sessions and valuable networking experiences.
